
LIFECOME BIOCHEMISTRY CO., LTD. — Investor Relations & Filings
Lifecome Biochemistry Co., Ltd. focuses on the research, development, and large-scale production of fermentation-based veterinary pharmaceuticals and feed additives. The company’s core product portfolio includes Bacitracin Zinc, Bacitracin Methylene Disalicylate (BMD), and Colistin Sulfate, available in both active pharmaceutical ingredient (API) and premix forms. These biochemical products are primarily utilized in the livestock and poultry sectors to manage enteric health and improve feed efficiency. The organization operates advanced fermentation and purification facilities, maintaining compliance with international Good Manufacturing Practices (GMP) and various global regulatory standards. By leveraging specialized biotechnological processes, the company provides high-purity solutions aimed at enhancing animal nutrition and disease prevention across international markets.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于控股股东、股东协议转让股份暨控制权拟发生变更的进展公告 | 2025-09-29 | Chinese | |
| 北京博星证券投资顾问有限公司关于绿康生化股份有限公司详式权益变动报告书之财务顾问核查意见(更新稿) | 2025-09-29 | Chinese | |
| 纵腾网络详式权益变动报告书(更新稿) | 2025-09-29 | Chinese | |
| 简式权益变动报告书(皓赢投资)(更新稿) | 2025-09-29 | Chinese | |
| 简式权益变动报告书(义睿投资)(更新稿) | 2025-09-29 | Chinese | |
| 关于召开2025年第三次临时股东会的提示性公告 | 2025-09-29 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 38149823 | 关于控股股东、股东协议转让股份暨控制权拟发生变更的进展公告 | 2025-09-29 | Chinese | ||
| 38149807 | 北京博星证券投资顾问有限公司关于绿康生化股份有限公司详式权益变动报告书之财务顾问核查意见(更新稿) | 2025-09-29 | Chinese | ||
| 38149786 | 纵腾网络详式权益变动报告书(更新稿) | 2025-09-29 | Chinese | ||
| 38149784 | 简式权益变动报告书(皓赢投资)(更新稿) | 2025-09-29 | Chinese | ||
| 38149766 | 简式权益变动报告书(义睿投资)(更新稿) | 2025-09-29 | Chinese | ||
| 38149750 | 关于召开2025年第三次临时股东会的提示性公告 | 2025-09-29 | Chinese | ||
| 38149724 | 绿康生化股份有限公司审阅报告 | 2025-09-23 | Chinese | ||
| 38149699 | 关于本次交易相关内幕知情人买卖股票情况的自查报告的公告 | 2025-09-23 | Chinese | ||
| 38149684 | 绿康(玉山)胶膜材料有限公司评估报告(银信评报字(2025)第C00091号) | 2025-09-23 | Chinese | ||
| 38149659 | 浙商证券股份有限公司关于绿康生化股份有限公司本次交易相关内幕知情人买卖股票情况的自查报告的核查意见 | 2025-09-23 | Chinese | ||
| 38149640 | 绿康生化股份有限公司重大资产出售暨关联交易报告书(草案)(修订稿) | 2025-09-23 | Chinese | ||
| 38149638 | 绿康生化股份有限公司拟置出资产模拟审计报告 | 2025-09-23 | Chinese | ||
| 38149602 | 绿康生化股份有限公司关于深圳证券交易所重大资产出售问询函的回复 | 2025-09-23 | Chinese | ||
| 38149600 | 第五届董事会第二十二次(临时)会议决议公告 | 2025-09-23 | Chinese | ||
| 38149587 | 浙商证券股份有限公司关于绿康生化股份有限公司重大资产出售暨关联交易独立财务顾问报告(修订稿) | 2025-09-23 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
LIFECOME BIOCHEMISTRY CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/54867/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=54867 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=54867 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=54867 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 54867}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for LIFECOME BIOCHEMISTRY CO., LTD. (id: 54867)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.